Guidelines For Management Of Jaundice Research Articles

Evaluasi Tingkat Pengetahuan Perawat tentang Terapi Stimulasi Fisik pada Hiperbilirubinemia Neonatus

Background. Infants with hyperbilirubin have management in lowering bilirubin levels. Management of the physiological management of jaundice is regular drinking with frequent breastfeeding and light therapy if possible. WHO guidelines for the pathological management of jaundice can be carried out by phototherapy and pharmacology. Physical stimulation therapy is a complementary therapy in the form of passive Range of Motion (ROM) movements. The aim of the study was to evaluate the level of knowledge of nurses about physical stimulation therapy in hyperbilirubinemia neonates.
 Methods. This study used a quasi-experiment with a one-group pretest-posttest design approach. The research was conducted in May-August 2020 in virtual or online due to the Covid 19 pandemic situation. The number of respondents was 30 people. Data collection using a modified questionnaire by the researcher. The data were then processed and analyzed using univariate analysis and bivariate analysis using the Paired Sample T-Test.
 Results. The mean pre-test score was 77.18 and the post-test mean score was 93.74. The statistical test results showed a difference in knowledge before and after education with a p-value of 0.000 (p <0.05).
 Conclusion. Nurses' level of knowledge about physical stimulation therapy increased after being given an education.

ABM Clinical Protocol #22: Guidelines for Management of Jaundice in the Breastfeeding Infant 35 Weeks or More of Gestation-Revised 2017.

A central goal of The Academy of Breastfeeding Medicine is the development of clinical protocols free from commercial interest or influence for managing common medical problems that may impact breastfeeding success. These protocols serve only as guidelines for the care of breastfeeding mothers and infants and do not delineate an exclusive course of treatment or serve as standards of medical care. Variations in treatment may be appropriate according to the needs of an individual patient.

The Italian Registry of kernicterus and hyperbilirubinaemia

Aim: to monitor the incidence of cases of kernicterus and severe hyperbilirubinemia in Italy over time, and to describe each single registered event with sufficient information in order to identify one or more possible failures in the management of jaundice. Methods: the Task Force on hyperbilirubinemia of the Italian Society of Neonatology will draw up national guidelines for management of jaundice in the newborn and a national registry of kernicterus and hyperbilirubinemia for newborns with a gestational age greater than 34. Results and Conclusions: the choice of the inclusion criteria for the registry and the minimum information necessary to describe each single event registered are reported and will be discussed at the national congress of the Italian Society of Neonatology next October 2012.

ABM Clinical Protocol #22: Guidelines for Management of Jaundice in the Breastfeeding Infant Equal to or Greater Than 35 Weeks' Gestation

A central goal of The Academy of Breastfeeding Medicine is the development of clinical protocols for managing common medical problems that may impact breastfeeding success. These protocols serve only as guidelines for the care of breastfeeding mothers and infants and do not delineate an exclusive course of treatment or serve as standards of medical care. Variations in treatment may be appropriate according to the needs of an individual patient.

Yet Another Expert Opinion on Bilirubin Toxicity!

Drs Newman and Maisels1 have provided valuable new guidelines for management of jaundice in the term newborn which take into account age at discharge from the hospital and some of the factors altering the general risk of bilirubin toxicity. They note that much of the information needed to identify the individual at risk is still unavailable and remind their readers that their "recommendations should be reevaluated periodically as new data become available." I have serious concerns, however, with the second half of their paper which almost completely downplays the toxic potential of bilirubin, its often erratic expression, and its ability to cause a spectrum of damage ranging from frank kernicterus to insults that are so minor as to be compensated for completely over time.2-4